Blog

I caught a report from OptumRx of “Five Drugs Set to Have the Biggest Impact on Payers and Patients.” It’s ...

There’s a lot of attention going to Acthar Gel and how Medicaid has stripped it of its favorable rebate status, ...

Both the general press and the trade press have delighted in predicting great injury (if not even death) to Mallinckrodt ...

The world of launching a new healthtech product is outrageously complicated in our era. Even large and sophisticated devicemakers can ...